These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27317085)

  • 41. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology.
    Helms PJ; Ekins Daukes S; Taylor MW; Simpson CR; McLay JS
    Br J Clin Pharmacol; 2005 Jun; 59(6):684-90. PubMed ID: 15948933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
    Ellul IC; Grech V; Attard-Montalto S
    Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Off-label medicine use in children and adolescents: results of a population-based study in Germany.
    Knopf H; Wolf IK; Sarganas G; Zhuang W; Rascher W; Neubert A
    BMC Public Health; 2013 Jul; 13():631. PubMed ID: 23822744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia.
    Bilal AI; Osman ED; Mulugeta A
    BMC Health Serv Res; 2016 Apr; 16():144. PubMed ID: 27106610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug utilization pattern in children and off-label use of medicines in a pediatric intensive care unit.
    Blanco-Reina E; Medina-Claros AF; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Ruiz-Extremera Á
    Med Intensiva; 2016; 40(1):1-8. PubMed ID: 25583042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in accessibility to medicines for children in New Zealand: 1998-2002.
    Chui J; Tordoff J; Kennedy J; Reith D
    Br J Clin Pharmacol; 2004 Mar; 57(3):322-7. PubMed ID: 14998428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with medicine use among children aged under 12 years--a population survey in Finland.
    Hämeen-Anttila K; Lindell-Osuagwu L; Sepponen K; Vainio K; Halonen P; Ahonen R
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):400-7. PubMed ID: 19937988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paediatric formulations--getting to the heart of the problem.
    Standing JF; Tuleu C
    Int J Pharm; 2005 Aug; 300(1-2):56-66. PubMed ID: 15979830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paediatric medicines research in the UK: how to move forward?
    Wong I; Sweis D; Cope J; Florence A
    Drug Saf; 2003; 26(8):529-37. PubMed ID: 12825967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Off-label and unlicensed paediatric prescribing in a community setting: a prospective longitudinal cohort study in Malta.
    Ellul IC; Grech V
    Paediatr Int Child Health; 2014 Feb; 34(1):12-8. PubMed ID: 24502853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rational use of medicines: assessing progress using primary health centres in Shomolu local government area of Lagos, Nigeria.
    Oyeyemi AS; Ogunleye OA
    West Afr J Med; 2013; 32(2):121-5. PubMed ID: 23913500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Access to medicines in remote and rural areas: a survey of residents in the Scottish Highlands & Western Isles.
    Rushworth GF; Diack L; MacRobbie A; Munoz SA; Pfleger S; Stewart D
    Public Health; 2015 Mar; 129(3):244-51. PubMed ID: 25698496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computer calculated dose in paediatric prescribing.
    Kirk RC; Li-Meng Goh D; Packia J; Min Kam H; Ong BK
    Drug Saf; 2005; 28(9):817-24. PubMed ID: 16119974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric off-label drug use in China: risk factors and management strategies.
    Zhang L; Li Y; Liu Y; Zeng L; Hu D; Huang L; Chen M; Lv J; Yang C
    J Evid Based Med; 2013 Feb; 6(1):4-18. PubMed ID: 23557523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Off-label prescribing for allergic diseases in pre-school children.
    Morais-Almeida M; Cabral AJ
    Allergol Immunopathol (Madr); 2014; 42(4):342-7. PubMed ID: 23769737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survey of off-label prescribing in a university paediatric outpatient in Brazil.
    Monteiro FASG; Soares CN; Chaveiro LG; Cabral VA; Lima PMA
    Trop Doct; 2022 Apr; 52(2):270-275. PubMed ID: 35037806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
    Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.